A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer

NCT03575013 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Avelumab
DRUG: Docetaxel

Sponsor

Yousef Zakharia

Collaborators

[object Object]
[object Object]